The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Thrombosis and Hemostasis
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Thrombosis and Hemostasis.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Thrombosis and Hemostasis.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Thrombosis and Hemostasis are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
18. International Conference on Thrombosis and Hemostasis has teamed up with the Special Journal Issue on
Thrombosis and Hemostasis.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Digital Program consists of the e-proceedings book which is available online-only
and includes the conference communications (proceedings abstracts and papers).
Registered participants can access the digitally available conference
proceedings ( and certificates ) by visiting their profile pages.
Clinical hemostasis and hemorheology
Thrombosis in oncology and oncohematology
Thrombosis and hemorrhage in obstetrics
Thrombosis and hemorrhage in surgery and traumatology-orthopedics
Coagulation disorders in ICU
Pathology of platelet-mediated hemostasis and vascular wall. Antiplatelet and angioprotective agents
Venous thromboembolism
Hemocoagulation problems in pediatrics and neonatology
Arterial and venous thrombosis in cardiology and neurology
Organ blood flow disorders, microcirculation and blood rheology
Pharmacogenomics
Warfarin and new oral anticoagulant. New indications for NOAK
Heparins: past, present and future
Clinical transfusiology and hemostasis disorders
Acute bleeding, care and preventions. Patient's blood management
Hemophilia. Thrombocytopathias. Von Willebrand Disease
An Update on Laboratory Diagnostics in hemostasis and hemorheology
Autoimmune diseases and pathology of hemostasis
New tools for diagnosis, therapy and prevention of hemostasis disorders and blood rheology disturbances
Thrombolytic therapy
Basic research for clinical practice
| Abstracts/Full-Text Paper Submission Deadline |
|
November 28, 2024 |
| Notification of Acceptance/Rejection |
|
December 12, 2024 |
| Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
November 26, 2024 |
| Conference Dates |
|
December 30-31, 2024 |
